Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

• Conditions: Cognitive Impairment; Alzheimer Disease
• Interventions: Diagnostic Test: MemScreen

• Registration Number: NCT03811184
• Lead Sponsor: MemScreen

Brief Summary

The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions.

The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests.

The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen.

The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.

Detailed Description

Characteristics of MemScreen :

* Smartphone / tablet application developed by the Cognitive Neurology Center at Lariboisière - Fernand Widal Hospital to explore a patient with a cognitive disorder.

* The application is a self-test by the patient under the supervision of a doctor.

* The doctor has an account to be able to pass the test to patients.

* The tablet test is anonymous without the possibility to identify the patient.

Study Timeline

• Status Verified: 2019-01
• Study Start: 2019-01-17
• Study First Submitted: 2019-01-17
• Study First Submitted QC: 2019-01-18
• Study First Posted: 2019-01-22
• Last Update Submitted: 2019-08-14
• Last Update Posted: 2019-08-15
• Primary Completion: 2020-03
• Study Completion: 2020-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• Major patients followed in memory clinic.
• Performing a neuropsychological assessment less than 6 months old.
• No visual or motor deficiency impeding the use of a digital tablet.

Exclusion Criteria

• None.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
MemScreen	MemScreen	Each participants will undergo MemScreen : a screening tool on smartphone for detecting mild cognitive impairment.

Primary Outcome Measures

Name	Time	Method
Ability to detect patients with mild cognitive impairment.	through study completion, an average of 6 months	To evaluate the ability of MemScreen to discriminate patients with an objective memory disorder from a validated neuropsychological reference test: the free and cued selective reminding test.

Trial Locations

Locations (1)

Centre Neurologie Cognitive Hôpital Fernand Widal; 🇫🇷 Paris, France